Research ExplorerPublicationsHuman kallikrein 8, a novel biomarker for ovarian carcinoma

Human kallikrein 8, a novel biomarker for ovarian carcinoma

Standard

Human kallikrein 8, a novel biomarker for ovarian carcinoma. / Kishi, Tadaaki; Grass, Linda; Soosaipillai, Antoninus; Scorilas, Andreas; Harbeck, Nadia; Schmalfeldt, Barbara; Dorn, Julia; Mysliwiec, Michal; Schmitt, Manfred; Diamandis, Eleftherios P.

In: CANCER RES, Vol. 63, No. 11, 01.06.2003, p. 2771-4.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Kishi, T, Grass, L, Soosaipillai, A, Scorilas, A, Harbeck, N, Schmalfeldt, B, Dorn, J, Mysliwiec, M, Schmitt, M & Diamandis, EP 2003, 'Human kallikrein 8, a novel biomarker for ovarian carcinoma', CANCER RES, vol. 63, no. 11, pp. 2771-4.

APA

Kishi, T., Grass, L., Soosaipillai, A., Scorilas, A., Harbeck, N., Schmalfeldt, B., Dorn, J., Mysliwiec, M., Schmitt, M., & Diamandis, E. P. (2003). Human kallikrein 8, a novel biomarker for ovarian carcinoma. CANCER RES, 63(11), 2771-4.

Vancouver

Kishi T, Grass L, Soosaipillai A, Scorilas A, Harbeck N, Schmalfeldt B et al. Human kallikrein 8, a novel biomarker for ovarian carcinoma. CANCER RES. 2003 Jun 1;63(11):2771-4.

Bibtex

@article{dbca460c3f4b4474ae4277fe408b1e81,
title = "Human kallikrein 8, a novel biomarker for ovarian carcinoma",
abstract = "Human kallikrein 8 (hK8; neuropsin) is a serine protease and new member of the hK family. The aim of this study was to examine if hK8 may serve as a novel cancer biomarker. An hk8-ELISA, developed in-house, was used to study the distribution of hK8 in various biological fluids and tissue extracts from healthy individuals and ovarian cancer patients of different stages of the disease (International Federation of Obstetrics and Gynecology II-IV). For ovarian cancer patients, very high levels in ascites fluid were observed (",
keywords = "Ascitic Fluid, Chromatography, High Pressure Liquid, Cytosol, Female, Humans, Immunoassay, Kallikreins, Neoplasm Staging, Ovarian Neoplasms, Tumor Markers, Biological",
author = "Tadaaki Kishi and Linda Grass and Antoninus Soosaipillai and Andreas Scorilas and Nadia Harbeck and Barbara Schmalfeldt and Julia Dorn and Michal Mysliwiec and Manfred Schmitt and Diamandis, {Eleftherios P}",
year = "2003",
month = jun,
day = "1",
language = "English",
volume = "63",
pages = "2771--4",
journal = "CANCER RES",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

RIS

TY - JOUR

T1 - Human kallikrein 8, a novel biomarker for ovarian carcinoma

AU - Kishi, Tadaaki

AU - Grass, Linda

AU - Soosaipillai, Antoninus

AU - Scorilas, Andreas

AU - Harbeck, Nadia

AU - Schmalfeldt, Barbara

AU - Dorn, Julia

AU - Mysliwiec, Michal

AU - Schmitt, Manfred

AU - Diamandis, Eleftherios P

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Human kallikrein 8 (hK8; neuropsin) is a serine protease and new member of the hK family. The aim of this study was to examine if hK8 may serve as a novel cancer biomarker. An hk8-ELISA, developed in-house, was used to study the distribution of hK8 in various biological fluids and tissue extracts from healthy individuals and ovarian cancer patients of different stages of the disease (International Federation of Obstetrics and Gynecology II-IV). For ovarian cancer patients, very high levels in ascites fluid were observed (

AB - Human kallikrein 8 (hK8; neuropsin) is a serine protease and new member of the hK family. The aim of this study was to examine if hK8 may serve as a novel cancer biomarker. An hk8-ELISA, developed in-house, was used to study the distribution of hK8 in various biological fluids and tissue extracts from healthy individuals and ovarian cancer patients of different stages of the disease (International Federation of Obstetrics and Gynecology II-IV). For ovarian cancer patients, very high levels in ascites fluid were observed (

KW - Ascitic Fluid

KW - Chromatography, High Pressure Liquid

KW - Cytosol

KW - Female

KW - Humans

KW - Immunoassay

KW - Kallikreins

KW - Neoplasm Staging

KW - Ovarian Neoplasms

KW - Tumor Markers, Biological

M3 - SCORING: Journal article

C2 - 12782581

VL - 63

SP - 2771

EP - 2774

JO - CANCER RES

JF - CANCER RES

SN - 0008-5472

IS - 11

ER -